UK pharma major GSK reported better-than-expected second-quarter 2026 results, helped by continued growth in Specialty ...

ViiV Healthcare's two-drug HIV pill Dovato (dolutegravir/lamivudine) has matched the efficacy of Gilead's market-leading ...

US obesity specialist Ambrosia Biosciences has strengthened its clinical and scientific ranks, naming cardiometabolic drug ...

US biotech Apnimed has set the terms for its long-awaited initial public offering, seeking to raise up to $150 million as it prepares for a potential commercial launch of its lead obstructive sleep ...

The Pharmaceutical Section of the Manufacturers' Association of Israel, which represents over 201 drug companies, has sponsored the publication in English of the Guidelines for Fi ...

A commercial-stage biopharmaceutical company focused on respiratory disease and other specialty conditions. Theravance Biopharma develops and commercializes small-molecule medicines, combining ...

Cambridge Antibody Technology is the latest firm to join the Pfizer-Gen network of alliances, which Pfizer initiated in 1995 to expand its biotechnology expertise. As a result, CAT has signed a ...

A clinical‑stage biopharma company based California, focused on therapies for CNS disorders. Founded by experts in psychiatry and neuroscience to target neural circuits causally linked to disease, the ...

Positive high-level results from the CLARITY-Gastric01 global Phase III trial showed that sonesitatug vedotin (Sone-Ve) ...

Cambridge, USA-based biotech Oak Hill Bio this morning announced plans to go public via a combination with RA Capital-backed ...

Shares of US biotech Forte Biosciences shot up nearly 40% to $76.40 in early trading, on the news of a takeover bid from ...

US clinical-stage US autoimmune drug developerKyverna Therapeutics (Nasdaq: KYTX) and ElevateBio, a contract development and manufacturing organization (CDMO), today announced a manufacturing ...